Top marks for Cherwell’s Redipor prepared microbial media products
Extensive range of ready-to-use culture media available in bottles and plates.
A recent customer satisfaction survey has affirmed that the vast majority would recommend Cherwell and its Redipor microbiological media products to a colleague. Value for money, excellent customer service and product quality were all key factors contributing to the very positive outcome of this survey. These results are evidenced by Redipor’s growing user base within the pharmaceutical and associated industries both domestically and across Europe. Therefore, to accommodate all customers, Cherwell has just released both UK and Euro versions of its 2018/19 Redipor Prepared Media price list, now available to download from Cherwell’s website.
Redipor prepared media products scored highly with customers in Cherwell’s recent survey to achieve an impressive Net Promoter Score of +76 (from a range of -100 to +100). Customer comments as to ‘Why Cherwell?’ included: ”The excellent service; great pricing; exceeding expectations with delivery times; helping us out in a crisis; flexibility by preparing bespoke media; pragmatic advice; and realistic timeframes. What more could anyone want?”
Meeting varying customer needs, such as for environmental monitoring, sterility testing and validation applications, the new Redipor price list details the extensive range of ready-to-use culture media available in bottles and plates. Cherwell provides a selection of the most commonly requested types, many of which are available from stock for next day delivery. In addition to those included in the price list, Cherwell offers many other bespoke products which are made to order with short lead times and small minimum order requirements. Discounts are available for high volume and standing orders.
“With customer satisfaction and ease of access in mind, we have laid out our new Redipor price list to enable straightforward reference of ordering information and products,” said Andrew Ramage, Cherwell’s Microbiology Product Specialist. “And if customers can't find exactly what they need, we’d like to hear from them as we frequently adapt to meet specific requirements, be it the media formulation, format, packaging or quantity. We are also very happy to provide rapid quotations and flexible delivery schedules.”
Related News
-
News WuXi to sell CGT manufacturing unit to US-based Altaris LLC
At the tail end of 2024, Chinese-based CDMO WuXi AppTec announced the signing of their deal with private equity firm Altaris LLC, confirming the sale of WuXi Advanced Therapies, the cell and gene therapy manufacturing arm of WuXi AppTec. -
News Women in Pharma: Our hopes for 2025 and beyond
Our last instalment for 2024 of the Women in Pharma series brings you messages direct from the Informa Markets CPHI team as they discuss the advice and insights they have carried throughout their roles working at CPHI, and what they hope to see for the... -
News CPHI Milan Wrap-Up Report: Conference Highlights
Discover the emerging and trending topics of the pharmaceutical industry with our CPHI Milan Conference Highlights, with exclusive insight from pharmaceutical leaders and experts! -
News BIOSECURE Act not included in key defense spending bill for 2025
On December 7, 2024, the Biden administration revealed the 2025 National Defense Authorization Act, an annual defense bill specifying the budget and expenditures of the US Department of Defense. The controversial BIOSECURE Act was notably missing from ... -
News Lessons from CPHI Milan 2024: Sunny Intervals for Pharma Manufacturing?
As the 2024 CPHI conference wrapped up in Milan, we caught up with L.E.K. Consulting – a global strategy consulting firm with deep expertise in pharma manufacturing – to discuss evolving market perspectives and business outlook. -
News Trump 2.0: What does the US election result mean for the healthcare industry?
After Trump won the Presidential election in the US in early November, we take a look at some of the implications a new Trump administration could have on the health and pharmaceutical industry, and on US patients. -
News Women in Pharma: Reflections from Behind the Scenes
In this instalment of our monthly series, the team that brings you the Women in Pharma series each month sits down for a heart-to-heart on what the series means to them, and how they hope to continue their work in the future. -
News Scaling the Industry: CPHI Scale-Up Market interview with YSK Laboratories
For the first time, CPHI Milan hosted the CPHI Start-Up Market, expanding support for emerging and small-sized enterprises in their transition to the next level of growth. In this interview, we spoke with Yuvansh Khokhani, Managing Director of YSK Labo...
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance